Showing results (1731-1740 of 2,430) with videos related to
Sort By:
Pageof 243
Annals of Internal Medicine|December 2, 2009
Development and validation of a patient self-assessment score for diabetes riskHeejung Bang, Alison M Edwards, Andrew S Bomback, et al.Obesity (Silver Spring, Md.)|October 4, 2008
Increased myocardial susceptibility to repetitive ischemia with high-fat diet-induced obesityGeeta D Thakker, Nikolaos G Frangogiannis, Pawel T Zymek, et al.Atherosclerosis|July 10, 2012
ApoE and the role of very low density lipoproteins in adipose tissue inflammationJiali Wang, Xiaoyuan Dai Perrard, Jerry L Perrard, et al.Cardiology and Therapy|November 24, 2025
Real-World Adherence and Effectiveness of Inclisiran in Lowering LDL-C: Results from 1 Year of Follow-UpChristie M Ballantyne, Timothy E Graham, Lucinda J Van Anglen, et al.Circulation|April 30, 2003
Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trialChristie M Ballantyne, John Houri, Alberto Notarbartolo, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|January 28, 2021
Conventional and Novel Lipid Measures and Risk of Peripheral Artery DiseaseMinghao Kou, Ning Ding, Shoshana H Ballew, et al.Journal of Clinical Lipidology|March 6, 2012
Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reductionPeter P Toth, Christie M Ballantyne, Michael H Davidson, et al.Journal of Clinical Lipidology|December 3, 2010
Safety of extended-release niacin/laropiprant in patients with dyslipidemiaJames McKenney, Harold Bays, Michael Koren, et al.Plos One|May 5, 2015
Strategies to rescue the consequences of inducible arginase-1 deficiency in miceLaurel L Ballantyne, Yuan Yan Sin, Tim St Amand, et al.Journal of the American Heart Association|March 26, 2017
An NPPB Promoter Polymorphism Associated With Elevated N-Terminal pro-B-Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and MortalitySara B Seidelmann, Orly Vardeny, Brian Claggett, et al.Pageof 243